国产91视频久久,亚洲综合色图在线观看,五月天操逼网,日韩色色AV,青青在线A片,亚洲最大色在线观看,欧美熟妇丝袜诱惑,青青操逼视频,日韩无码操出水

Guideview > Legend Biotech

Legend Biotech 2024 Financial Performance Financial statements Legend Biotech reports 2024 revenue of $963M for CARVYKTI?. Over 5,000 patients treated, with expanded manufacturing and reimbursement approvals. Positive Phase 3 data shows high MRD negativity rates in multiple myeloma patients. Strong financial outlook for 2026.
Speculation Arises from Genscript's Financial Changes: Is Legend Biotech About to Be Sold? GenScript Speculation is rising about the potential sale of Legend Biotech after Genscript Biotech's recent financial restructuring. By deconsolidating Legend, Genscript reduces exposure to its losses while increasing investor speculation about a possible acquisition. Could this be Legend's next big move?

Articles Archives

Hot Articles

All Categories